SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011
2011年7月22日 - 7:00PM
ビジネスワイヤ(英語)
SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated
to discovery and development of novel cancer therapies, announced
that it will release its 2011 second quarter financial results on
Wednesday, August 3, 2011. SuperGen's new management team will
provide details of the Company's financial results and revised
outlook for the future.
A press release will be issued at 5:00 a.m. PST on August 3rd.
The Company will host a webcast conference call to discuss the
results one hour later at 6 a.m. PST. A live webcast of the call
will be available in the Investor Events section of the Company's
website at www.supergen.com. A webcast replay of the live
conference call will be available shortly following the event.
Alternatively, you may access a replay of the conference call by
dialing (855) 859-2056 (domestic) and (404) 537-3406
(international); replay passcode number is 85860139. The webcast
replay and conference call replay will be available for 30
days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to discovery and
development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. On July 20, 2011 SuperGen closed
the transaction to acquire Astex Therapeutics Limited, a privately
held, UK-based biotechnology company developing targeted
therapies.
For more information about SuperGen, please visit
http://www.supergen.com.
Supergen, Inc. (MM) (NASDAQ:SUPG)
過去 株価チャート
から 5 2024 まで 6 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Supergen, Inc. (MM) (ナスダック市場): 0 recent articles
その他のSuperGen, Inc.ニュース記事